THBS1 and cancer: Whereas our pilot study based on IHC analyses is limited due to the low number of cases (i.e., 12 patients with TNBC), the inverse correlation between anti-cancer immune response and TSP1 expression is further documented by our in silico analyses on 253 TNBC patients.